Replies to post #26839 on US Stem Cell Inc (USRM)

[TheHungryHippo]

MYOCELL Clinical Trials Discussed in Video MUST WATCH

Quote from USRM filing:
"We estimate that the products and services we offer through US Stem Cell Training, Vet Biologics, and US Stem Cell Clinics has the potential, although we cannot provide assurances as to if and when it will be accomplished, to drive up to 100 million dollars in cumulative peak annual revenues."

"Our strategy is to expand the revenues generated from each of these operating divisions and to reinvest the profits we generate into our CLINICAL DEVELOPMENT PIPELINE"

Video about MYOCELL And Clinical Trials. MUST WATCH

"A PIVOTAL STUDY " Which means at the end of the study we could commercialize

A pivotal trial is a clinical trial or study intended to provide evidence for a drug marketing approval, e.g. by the United States Food and Drug Administration. Phase III trials are assumed to be pivotal so the phrase is often used for the rare pivotal phase II trials.

Look what it says on Clinicaltrials.gov:
Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)

The latest word from the company is that they will release the results VERY SOON (2-3weeks possibly)

Once these results are released, we may be able to put a much higher value on this company.

https://clinicaltrials.gov/ct2/show/NCT00526253?term=bioheart&rank=3

ClinicalTrials.gov Identifier:
NCT00526253
First received: September 6, 2007
Last updated: January 30, 2017
Last verified: January 2017